Safety study of FB-101 in healthy men
This early-phase trial tests an experimental oral medication called FB-101 in healthy adult men to check its safety and how the body processes it. It's a first step to see if the drug is safe enough for future studies in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man between 19 and 55 years old.
- You have not smoked or used nicotine products for at least 3 months.
- Your body mass index (BMI) is between 18.5 and 30.0.
- You are in good general health with no significant medical conditions, as judged by the study doctor.
- If not vasectomized, you must agree to use condoms with spermicide or avoid sex during the study and for 90 days after treatment, and not donate sperm during that time.
- You must be able to swallow multiple capsules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
This trial studies a new drug called FB418 to see if it's safe and how the body handles it. It first tests single doses in younger healthy men, then multiple doses, and also includes an optional group for healthy older adults.
This early-stage study tests whether a new drug called FB102 is safe in people without serious health conditions. Researchers will monitor volunteers closely to understand how the body handles the drug.
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.